BIOMET 3i launches new 3i T3 External Hex Implants
dlpmagazine.com-2014-02-01, Issue 2
BIOMET 3i, creator of the 3i T3 Implant, announced that it is launching its 3i T3 External Hex Implants.
BIOMET 3i, creator of the 3i T3 Implant, announced that it is launching its 3i T3 External Hex Implants.
The 3i T3 External Hex Implant is a contemporary hybrid implant with a multi-surface topography designed to deliver aesthetic results through tissue preservation
Features include:
Coarse Micron Topography: A resorbable media blasting process using calcium phosphate particles provides 10 micron features, which facilitate blood clot retention along the threaded body of the implant1,2.
Fine Micron Topography: A dual acid-etching process provides a 1-3 micron peak-to-peak surface (OSSEOTITE®) that supports platelet activation3,4. At the collar region of the implant, this surface is designed to mitigate the risk of peri-implantitis5.
Sub-Micron Topography: The option exists for a more complex topography with the Discrete Crystalline Deposition (DCD) of calcium phosphate nanoparticles. This surface treatment has demonstrated increased integration throughout the early healing process, helping to facilitate Bone Bonding®*6.
Use of the Gold-Tite® Screw with the patented Gold-Tite surface lubrication allows the screw to rotate further than a non-coated titanium screw7,8. This helps to provide a tight fit between implant components.
For more information, please contact your local BIOMET 3i Sales Representative. For more information about BIOMET 3i, please visit www.biomet3i.com or contact the company at (800) 342-5454; outside the U.S. dial (561) 776-6700.
1. Kuzyk PR, Schemitsch EH. The basic science of peri-implant bone healing. Indian J Orthop. 2011 Mar;45(2):108-15.
3. Kikuchi L, Park JY, Victor C, Davies JE†. Platelet interactions with calcium-phosphate-coated surfaces. Biomaterials 2005 Sep;26(26):5285-95.
4. Park JY, Gemmell CH, Davies JE†. Platelet interactions with titanium: modulation of platelet activity by surface topography. Biomaterials 2001 Oct;22(19):2671-82.
5. Zetterqvist L, Feldman S, Rotter B, Vincenzi G, Wennström JL, Chierico A, Stach RM††, Kenealy JN††. A prospective, multicenter, randomized controlled 5-year study of hybrid and fully etched implants for the incidence of peri-implantitis. J Periodontol 2010 April;81(4):493-501.
6. Lin A, Wang CJ, Kelly J, Gubbi P††, Nishimura I. The role of titanium implant surface modification with hydroxyapatite nanoparticles in progressive early bone-implant fixation in vivo. Int J Oral Maxillofac Implants 2009 Sep–Oct;24(5):808–816.
8. Byrne D, Jacobs S, O’Connell B, Houston F, Claffey N. Preloads generated with repeated tightening in three types of screws used in dental implant assemblies. J. Prosthodont. 2006 May–Jun;15(3):164-171.
† Dr. Davies has a financial relationship with BIOMET 3i LLC resulting from speaking engagements, consulting engagements and other retained services.
†† Dr. Gubbi, Dr. Kenealy, Dr. Stach, Mr. Suttin and Mr. Towse conducted this research while employed by BIOMET 3i.